Nathaniel Brown
- Hepatology top 0.05%
- Hepatitis C virus research 53
- Epidemiology top 0.2%
- Hepatitis B Virus Studies 49
- Liver Disease Diagnosis and Treatment 22
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 27
- Virology top 5%
- Neurology top 5%
-
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 7
-
- Viral-associated cancers and disorders 6
-
- Immunodeficiency and Autoimmune Disorders 5
- Co-authors
- Lynn D. CondreayEugene R. SchiffJules L. DienstagChing‐Lung LaiMary WoessnerZachary GoodmanTeresa L. WrightRobert G. Gish
- Partner nations
- United StatesChinaCanada
In The Last Decade
Nathaniel Brown
85 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 5.7k
- Epidemiology 6.0k
- Infectious Diseases 1.6k
- Virology 100
- Neurology 290
Countries citing papers authored by Nathaniel Brown
This map shows the geographic impact of Nathaniel Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Brown more than expected).
Fields of papers citing papers by Nathaniel Brown
This network shows the impact of papers produced by Nathaniel Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Brown. The network helps show where Nathaniel Brown may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nathaniel Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 2019 | 11 | |
| 3 | 2019 | 117 | |
| 4 | 2017 | 12 | |
| 5 | 2013 | 3 | |
| 6 | 2008 | 191 | |
| 7 | 2008 | 131 | |
| 8 | 2008 | 429 | |
| 9 | 2006 | 17 | |
| 10 | 2003 | 95 | |
| 11 | 2003 | 497 | |
| 12 | 2002 | 238 | |
| 13 | 2001 | 132 | |
| 14 | 1999 | 153 | |
| 15 | 1999 | 5 | |
| 16 | 1999 | 100 | |
| 17 | Lamivudine as Initial Treatment for Chronic Hepatitis B in the United Statesbreakdown → | 1999 | 976 |
| 18 | Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. | 1998 | 13 |
| 19 | Identification and characterization of mutations in hepatitis B virus resistant to lamivudinebreakdown → | 1998 | 675 |
| 20 | 1987 | 10 |
About Nathaniel Brown
Nathaniel Brown is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 87 papers that have together received 7.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (53 papers), Hepatitis B Virus Studies (49 papers), HIV/AIDS drug development and treatment (27 papers), Liver Disease Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). The work is most often cited by research in Hepatology (5.7k citations), Epidemiology (6.0k citations) and Infectious Diseases (1.6k citations). Nathaniel Brown has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lynn D. Condreay, Eugene R. Schiff, Jules L. Dienstag, Ching‐Lung Lai, Mary Woessner, Zachary Goodman, Teresa L. Wright, Robert G. Gish, George Chao and William H. Andrews. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Antimicrobial Agents and Chemotherapy and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.